NCI | Technology Transfer

HUMAN MONOCLONAL ANTIBODY TARGETING TNFR2 FOR CANCER IMMUNOTHERAPY

Read more about HUMAN MONOCLONAL ANTIBODY TARGETING TNFR2 FOR CANCER IMMUNOTHERAPY

European Patent
18727536.7
Filed on 2018-05-08

HUMAN MONOCLONAL ANTIBODY TARGETING TNFR2 FOR CANCER IMMUNOTHERAPY

Read more about HUMAN MONOCLONAL ANTIBODY TARGETING TNFR2 FOR CANCER IMMUNOTHERAPY

Canada
3059472
Filed on 2018-05-08

HUMAN MONOCLONAL ANTIBODY TARGETING TNFR2 FOR CANCER IMMUNOTHERAPY

Read more about HUMAN MONOCLONAL ANTIBODY TARGETING TNFR2 FOR CANCER IMMUNOTHERAPY

Australia
2018268970
Filed on 2018-05-08

METHODS FOR ISOLATING T CELLS HAVING ANTIGEN SPECIFICITY TO CANCER SPECIFIC MUTATIONS

Read more about METHODS FOR ISOLATING T CELLS HAVING ANTIGEN SPECIFICITY TO CANCER SPECIFIC MUTATIONS

Japan
2019-182421
Filed on 2019-10-02

ANTI-KRAS-G12D T CELL RECEPTORS

Read more about ANTI-KRAS-G12D T CELL RECEPTORS

Hong Kong
19133082.8
Filed on 2019-12-03

BRACHYURY POLYPEPTIDES AND METHODS FOR USE

Read more about BRACHYURY POLYPEPTIDES AND METHODS FOR USE

Denmark
15162282.6
Filed on 2008-02-27

TRITERPENE AMINE DERIVATIVES

Read more about TRITERPENE AMINE DERIVATIVES

Patent Cooperation Treaty
PCT/US2019/039981
Filed on 2019-06-28

HLA-A3-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS

Read more about HLA-A3-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS

US Application 16/662,808
Filed on 2019-10-24

HLA-A3-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS

Read more about HLA-A3-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS

Taiwan
108138456
Filed on 2019-10-24

HLA-A3-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS

Read more about HLA-A3-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS

Patent Cooperation Treaty
PCT/US2019/057833
Filed on 2019-10-24

Subscribe to NCI